Cargando…
Repeated Insulin-Like Growth Factor 1 Treatment in a Patient with Rett Syndrome: A Single Case Study
Rett syndrome (RTT) is a devastating neurodevelopmental disorder that has no cure. Patients show regression of acquired skills, motor, and speech impairment, cardio-respiratory distress, microcephaly, and stereotyped hand movements. The majority of RTT patients display mutations in the gene that cod...
Autores principales: | Pini, Giorgio, Scusa, M. Flora, Benincasa, Alberto, Bottiglioni, Ilaria, Congiu, Laura, Vadhatpour, Cyrus, Romanelli, Anna Maria, Gemo, Ilaria, Puccetti, Chetti, McNamara, Rachel, O’Leary, Seán, Corvin, Aiden, Gill, Michael, Tropea, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042280/ https://www.ncbi.nlm.nih.gov/pubmed/24918098 http://dx.doi.org/10.3389/fped.2014.00052 |
Ejemplares similares
-
IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients
por: Pini, Giorgio, et al.
Publicado: (2012) -
Rett syndrome: a wide clinical and autonomic picture
por: Pini, G., et al.
Publicado: (2016) -
Functional Network Mapping Reveals State-Dependent Response to IGF1 Treatment in Rett Syndrome
por: Keogh, Conor, et al.
Publicado: (2020) -
Illness Severity, Social and Cognitive Ability, and EEG Analysis of Ten Patients with Rett Syndrome Treated with Mecasermin (Recombinant Human IGF-1)
por: Pini, Giorgio, et al.
Publicado: (2016) -
Clinical and genetic Rett syndrome variants are defined by stable electrophysiological profiles
por: Keogh, Conor, et al.
Publicado: (2018)